Neurochemistry of drugs of abuse: cocaine, ibogaine, and substituted amphetamines
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
New York Acad. of Sciences
1998
|
| Schriftenreihe: | New York Academy of Sciences: Annals of the New York Academy of Sciences
844 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 362 S. Ill., graph. Darst. |
| ISBN: | 1573311456 1573311464 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012112644 | ||
| 003 | DE-604 | ||
| 005 | 19981109 | ||
| 007 | t | ||
| 008 | 980818s1998 ad|| |||| 10||| eng d | ||
| 020 | |a 1573311456 |9 1-57331-145-6 | ||
| 020 | |a 1573311464 |9 1-57331-146-4 | ||
| 035 | |a (OCoLC)38862816 | ||
| 035 | |a (DE-599)BVBBV012112644 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-20 | ||
| 050 | 0 | |a Q11 | |
| 050 | 0 | |a RM316 | |
| 082 | 0 | |a 615/.78 |2 21 | |
| 082 | 0 | |a 500 |2 21 | |
| 084 | |a XI 5805 |0 (DE-625)153018:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Neurochemistry of drugs of abuse |b cocaine, ibogaine, and substituted amphetamines |c ed. by Syed F. Ali |
| 264 | 1 | |a New York, NY |b New York Acad. of Sciences |c 1998 | |
| 300 | |a 362 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a New York Academy of Sciences: Annals of the New York Academy of Sciences |v 844 | |
| 650 | 4 | |a Amphétamines - Effets physiologiques - Congrès | |
| 650 | 4 | |a Cocaïne - Effets physiologiques - Congrès | |
| 650 | 4 | |a Drogues - Effets physiologiques - Congrès | |
| 650 | 7 | |a Drugs |2 gtt | |
| 650 | 7 | |a Drugsgebruik |2 gtt | |
| 650 | 4 | |a Ibogaine - Effets physiologiques - Congrès | |
| 650 | 7 | |a Neurochemie |2 gtt | |
| 650 | 4 | |a Neurochimie - Congrès | |
| 650 | 4 | |a Neurotoxicologie - Congrès | |
| 650 | 4 | |a Toxicomanie - Aspect physiologique - Congrès | |
| 650 | 4 | |a Toxicomanie - Chimiothérapie - Congrès | |
| 650 | 4 | |a Amphetamines |x Physiological effect |v Congresses | |
| 650 | 4 | |a Amphetamines |x pharmacology |v Congresses | |
| 650 | 4 | |a Brain |x drug effects |v Congresses | |
| 650 | 4 | |a Cocaine |x Physiological effect |v Congresses | |
| 650 | 4 | |a Cocaine |x pharmacology |v Congresses | |
| 650 | 4 | |a Drug abuse |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Drug abuse |x Physiological aspects |v Congresses | |
| 650 | 4 | |a Drugs of abuse |x Physiological effect |v Congresses | |
| 650 | 4 | |a Ibogaine |x Physiological effect |v Congresses | |
| 650 | 4 | |a Ibogaine |x pharmacology |v Congresses | |
| 650 | 4 | |a Neurochemistry |v Congresses | |
| 650 | 4 | |a Neurotoxicology |v Congresses | |
| 650 | 4 | |a Substance-Related Disorders |x physiopathology |v Congresses | |
| 650 | 0 | 7 | |a Neuropharmakologie |0 (DE-588)4041896-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neurotoxizität |0 (DE-588)4123836-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Rauschgift |0 (DE-588)4048610-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1997 |z Hamilton Bermudainseln |2 gnd-content | |
| 689 | 0 | 0 | |a Rauschgift |0 (DE-588)4048610-2 |D s |
| 689 | 0 | 1 | |a Neuropharmakologie |0 (DE-588)4041896-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Rauschgift |0 (DE-588)4048610-2 |D s |
| 689 | 1 | 1 | |a Neurotoxizität |0 (DE-588)4123836-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Ali, Syed F. |e Sonstige |4 oth | |
| 830 | 0 | |a New York Academy of Sciences: Annals of the New York Academy of Sciences |v 844 |w (DE-604)BV002532608 |9 844 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008201537&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008201537 | ||
Datensatz im Suchindex
| _version_ | 1804126717213671424 |
|---|---|
| adam_text | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume 844
May 30,1998
THE NEUROCHEMISTRY OF
DRUGS OF ABUSE
COCAINE, IBOGAINE, AND SUBSTITUTED
AMPHETAMINES
Editor and Conference Chair
Syed F. Ali
Contents
Preface. By The Editor x
Part I. Gene Expression and Molecular Mechanisms of Drug Addiction
Cocaine and the AP 1 Transcription Factor Complex. By Bruce T. Hope .... 1
The Serotonergic System Modulates the Cocaine Induced Expression of the
Immediate Early Genes egr 1 and c fos in Rat Brain. By N. Humblot, N.
Thiriet, S. Gobaille, D. Aunis, and J. Zwiller 7
Immunohistochemical Changes of the Transcription Regulatory Factors in
Rat Striatum after Methamphetamine Administration. By Tatsuyuki
Muratake, Kazuhiko Toyooka, Shigenobu Hayashi, Tomio
ichikawa, toshiro kumanishi, and yasuo takahashi 21
Unraveling Dopamine D3 Receptor Function in Response to Psychostimulants
Using a Genetic Approach. By Ming Xu 27
The MAP Kinase Cascade Is Activated prior to the Induction of Gliosis in the
l Methyl 4 phenyl l,2,3,6 tetrahydropyridine (MPTP) Model of
Dopaminergic Neurotoxicity. By James P. O Callaghan, Parthena M.
Martin, and Marc J. Mass 40
Cell Death Mediated by Amino Acid Transmitter Receptors in Human
Alcoholic Brain Damage: Conflicts in the Evidence. By P. R. Dodd and
J. M. Lewohl 50
This volume contains the papers from a satellite meeting of the International Society for Neu
rochemistry and the American Society for Neurochemistry entitled Cellular and Molecular Mech¬
anisms of Drugs of Abuse: Cocaine, Ibogaine, and Substituted Amphetamines, which was held in
Hamilton, Bermuda on July 16 18, 1997.
Part II. Drugs of Abuse and Medication Development: Cocaine
Phentermine and Fenfluramine: Preclinical Studies in Animal Models of
Cocaine Addiction. By Richard B. Rothman, Gregory I. Elmer, Toni
S. Shippenberg, William Rea, and Michael H. Baumann 59
Research Issues Related to Development of Medications for Treatment of
Cocaine Addiction. By Michael Klein 75
Part III. Role of Free Radicals in Drugs of Abuse Induced Neurotoxicity
Methamphetamine Induced Changes in Antioxidant Enzymes and Lipid
Peroxidation in Copper/Zinc Superoxide Dismutase Transgenic Mice. By
SUBRAMANIAM JAYANTHI, BRUCE LADENHEIM, AND JEAN LUD CADET ... 92
Methamphetamine Induced Rapid and Reversible Reduction in the Activities
of Tryptophan Hydroxylase and Dopamine Transporters: Oxidative
Consequences? By Glen R. Hanson, James W. Gibb, Ryan R.
Metzger, Jerry M. Kokoshka, and Annette E. Fleckenstein 103
A Selective Regional Response of Cultured Astrocytes to Methamphetamine.
By Alfreda Stadlin, Josephine W. S. Lau, and Y. K. Szeto 108
Effects of 7 Nitroindazole, an NOS Inhibitor on Methamphetamine Induced
Dopaminergic and Serotonergic Neurotoxicity in Mice. By Syed F. Ali
and Yossef Itzhak 122
Role of Calpain in Spinal Cord Injury: Effects of Calpain and Free Radical
Inhibitors. By N. L. Banik, D. C. Shields, S. Ray, B. Davis, D.
Matzelle, G. Wilford, and E. L. Hogan 131
Part IV. Specific Neuronal Markers in Substituted Amphetamines Induced
Neurotoxicity
In Vivo Correlates of Central Serotonin Function after High Dose
Fenfluramine Administration. By Michael H. Baumann, Mario A.
Ayestas, and Richard B. Rothman 138
The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity.
By Diane B. Miller, Syed F. Ali, James P. O Callaghan, and Susan
C. Laws 153
Noradrenergic Modulation of Methamphetamine Induced Striatal Dopamine
Depletion. By Francesco Fornai, Maria Grazia Alessandri, Maria
Tilde Torracca, Lucia Bassi, Vera Scalori, and Giovanni Umberto
Corsini 166
The Effects of Cocaine on Nonhuman Primate Brain Function Are Age
Dependent. By Merle G. Paule, Michael P. Gillam, and Paul
Morris 178
Acute Effects of Dexfenfluramine (d FEN) and Methylenedioxymeth
amphetamine (MDMA) before and after Short Course, High Dose
Treatment. By David L. Frederick, Syed F. Ali, Michael P. Gillam,
Jeff Gossett, William Slikker, Jr., and Merle G. Paule 183
Methamphetamine Treatment Affects Blood and Liver S Adenosylmethionine
(SAM) in Mice: Correlation with Dopamine Depletion in the Striatum.
By Craig A. Cooney, Carolyn K. Wise, Lionel A. Poirier, and Syed
F. Ali 191
Calcium Channel Antagonist Isradipine Attenuates Cocaine Induced Motor
Activity in Rats: Correlation with Brain Monoamine Levels. By K.
Mills, T. A. Ansah, S. F. Ali, and D. C. Shockley 201
Influence of Concurrent Heroin and Cocaine Abuse on the Adrenergic and
Serotonergic Systems in Man. By T. R. A. Macedo, C. A. Fontes
RlBEIRO, T. MORGADINHO, AND M. A. V. AbREU 208
Part V. Drugs of Abuse and Medication Development: Ibogaine
Mechanisms of Antiaddictive Actions of Ibogaine. By Stanley D. Glick
AND ISABELLE M. MAISONNEUVE 214
In Vivo Ibogaine Blockade and In Vitro PKC Action of Cocaine. By
Emmanuel S. Onaivi, Syed F. Ali, and Amitabha Chakrabarti 227
Effect of Ibogaine on the Various Sites of the NMDA Receptor Complex and
Sigma Binding Sites in Rat Brain. By Yossef Itzhak and Syed F. Ali .. 245
Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison
to MK 801. By Michael H. Baumann, Richard B. Rothman, and
Syed F. Ali 252
Alteration in Electroencephalogram and Monoamine Concentrations in Rat
Brain following Ibogaine Treatment. By Zbigniew Binienda, Michael
A. Beaudoin, Brett T. Thorn, D. Rebecca Prapurna, John R.
Johnson, C. Matthew Fogle, William Slikker, Jr., and
Syed F. Ali 265
Medication Development of Ibogaine as a Pharmacotherapy for Drug
Dependence. By Deborah C. Mash, Craig A. Kovera, Billy E. Buck,
Michael D. Norenberg, Paul Shapshak, W. Lee Hearn, and Juan
Sanchez Ramos 274
Part VI. Prenatal Exposure and Postnatal Outcome
Prenatal Cocaine Exposure Affects Postnatal Dopaminergic Systems in
Various Regions of the Rat Brain. By Sun Jo Choi, Elizabeth Mazzio,
Malak G. Kolta, and Karam F. A. Soliman 293
Repeated Neonatal Phencyclidine Treatment Impairs Performance of a Spatial
Task in Juvenile Rats. By Ratna Sircar and Jerry W. Rudy 303
Developmental Exposure to Methamphetamine: A Neonatal Model in the
Rat. By J. Gomes da Silva, M. C. Silva, and M. A. Tavares 310
Uterine Position Determines the Extent of Dopamine Reduction after
Chronic Prenatal Cocaine Exposure. By Jack W. Lipton, Heather S.
Robie, ZaoDung Ling, Debra E. Weese Mayer, and
Paul M. Carvey 314
The Effects of Gestational Cocaine Exposure on Pregnancy Outcome,
Postnatal Development, Cognition and Locomotion in Rats. By Sun Jo
Choi, Elizabeth Mazzio, and Karam F. A. Soliman 324
Gestational Cocaine Exposure Alters Postnatal Pituitary Adrenal Axis
Activity and Stress Endurance in Rats. By Sun Jo Choi, Elizabeth A.
Mazzio, Renee R. Reams, and Karam F. A. Soliman 336
Repeated Administration of Cocaine Alters Dopamine Uptake and Release in
the Striatum and Nucleus Accumbens. By Lynne H. Clay, Elizabeth A.
Mazzio, Malak G. Kolta, and Karam F. A. Soliman 346
Subject Index 356
Index of Contributors 361
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012112644 |
| callnumber-first | Q - Science |
| callnumber-label | Q11 |
| callnumber-raw | Q11 RM316 |
| callnumber-search | Q11 RM316 |
| callnumber-sort | Q 211 |
| callnumber-subject | Q - General Science |
| classification_rvk | XI 5805 |
| ctrlnum | (OCoLC)38862816 (DE-599)BVBBV012112644 |
| dewey-full | 615/.78 500 |
| dewey-hundreds | 600 - Technology (Applied sciences) 500 - Natural sciences and mathematics |
| dewey-ones | 615 - Pharmacology and therapeutics 500 - Natural sciences and mathematics |
| dewey-raw | 615/.78 500 |
| dewey-search | 615/.78 500 |
| dewey-sort | 3615 278 |
| dewey-tens | 610 - Medicine and health 500 - Natural sciences and mathematics |
| discipline | Allgemeine Naturwissenschaft Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03241nam a2200769 cb4500</leader><controlfield tag="001">BV012112644</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19981109 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980818s1998 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1573311456</subfield><subfield code="9">1-57331-145-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1573311464</subfield><subfield code="9">1-57331-146-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)38862816</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012112644</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">Q11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM316</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield><subfield code="2">21</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">500</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5805</subfield><subfield code="0">(DE-625)153018:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neurochemistry of drugs of abuse</subfield><subfield code="b">cocaine, ibogaine, and substituted amphetamines</subfield><subfield code="c">ed. by Syed F. Ali</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">New York Acad. of Sciences</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">362 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">New York Academy of Sciences: Annals of the New York Academy of Sciences</subfield><subfield code="v">844</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphétamines - Effets physiologiques - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cocaïne - Effets physiologiques - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drogues - Effets physiologiques - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugsgebruik</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ibogaine - Effets physiologiques - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neurochemie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurochimie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurotoxicologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicomanie - Aspect physiologique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicomanie - Chimiothérapie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain</subfield><subfield code="x">drug effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cocaine</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cocaine</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug abuse</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug abuse</subfield><subfield code="x">Physiological aspects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs of abuse</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ibogaine</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ibogaine</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurochemistry</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurotoxicology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield><subfield code="x">physiopathology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neuropharmakologie</subfield><subfield code="0">(DE-588)4041896-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neurotoxizität</subfield><subfield code="0">(DE-588)4123836-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rauschgift</subfield><subfield code="0">(DE-588)4048610-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1997</subfield><subfield code="z">Hamilton Bermudainseln</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Rauschgift</subfield><subfield code="0">(DE-588)4048610-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neuropharmakologie</subfield><subfield code="0">(DE-588)4041896-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Rauschgift</subfield><subfield code="0">(DE-588)4048610-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Neurotoxizität</subfield><subfield code="0">(DE-588)4123836-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ali, Syed F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">New York Academy of Sciences: Annals of the New York Academy of Sciences</subfield><subfield code="v">844</subfield><subfield code="w">(DE-604)BV002532608</subfield><subfield code="9">844</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008201537&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008201537</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1997 Hamilton Bermudainseln gnd-content |
| genre_facet | Konferenzschrift 1997 Hamilton Bermudainseln |
| id | DE-604.BV012112644 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:21:53Z |
| institution | BVB |
| isbn | 1573311456 1573311464 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008201537 |
| oclc_num | 38862816 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-20 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-20 |
| physical | 362 S. Ill., graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | New York Acad. of Sciences |
| record_format | marc |
| series | New York Academy of Sciences: Annals of the New York Academy of Sciences |
| series2 | New York Academy of Sciences: Annals of the New York Academy of Sciences |
| spelling | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines ed. by Syed F. Ali New York, NY New York Acad. of Sciences 1998 362 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier New York Academy of Sciences: Annals of the New York Academy of Sciences 844 Amphétamines - Effets physiologiques - Congrès Cocaïne - Effets physiologiques - Congrès Drogues - Effets physiologiques - Congrès Drugs gtt Drugsgebruik gtt Ibogaine - Effets physiologiques - Congrès Neurochemie gtt Neurochimie - Congrès Neurotoxicologie - Congrès Toxicomanie - Aspect physiologique - Congrès Toxicomanie - Chimiothérapie - Congrès Amphetamines Physiological effect Congresses Amphetamines pharmacology Congresses Brain drug effects Congresses Cocaine Physiological effect Congresses Cocaine pharmacology Congresses Drug abuse Chemotherapy Congresses Drug abuse Physiological aspects Congresses Drugs of abuse Physiological effect Congresses Ibogaine Physiological effect Congresses Ibogaine pharmacology Congresses Neurochemistry Congresses Neurotoxicology Congresses Substance-Related Disorders physiopathology Congresses Neuropharmakologie (DE-588)4041896-0 gnd rswk-swf Neurotoxizität (DE-588)4123836-9 gnd rswk-swf Rauschgift (DE-588)4048610-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1997 Hamilton Bermudainseln gnd-content Rauschgift (DE-588)4048610-2 s Neuropharmakologie (DE-588)4041896-0 s DE-604 Neurotoxizität (DE-588)4123836-9 s Ali, Syed F. Sonstige oth New York Academy of Sciences: Annals of the New York Academy of Sciences 844 (DE-604)BV002532608 844 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008201537&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines New York Academy of Sciences: Annals of the New York Academy of Sciences Amphétamines - Effets physiologiques - Congrès Cocaïne - Effets physiologiques - Congrès Drogues - Effets physiologiques - Congrès Drugs gtt Drugsgebruik gtt Ibogaine - Effets physiologiques - Congrès Neurochemie gtt Neurochimie - Congrès Neurotoxicologie - Congrès Toxicomanie - Aspect physiologique - Congrès Toxicomanie - Chimiothérapie - Congrès Amphetamines Physiological effect Congresses Amphetamines pharmacology Congresses Brain drug effects Congresses Cocaine Physiological effect Congresses Cocaine pharmacology Congresses Drug abuse Chemotherapy Congresses Drug abuse Physiological aspects Congresses Drugs of abuse Physiological effect Congresses Ibogaine Physiological effect Congresses Ibogaine pharmacology Congresses Neurochemistry Congresses Neurotoxicology Congresses Substance-Related Disorders physiopathology Congresses Neuropharmakologie (DE-588)4041896-0 gnd Neurotoxizität (DE-588)4123836-9 gnd Rauschgift (DE-588)4048610-2 gnd |
| subject_GND | (DE-588)4041896-0 (DE-588)4123836-9 (DE-588)4048610-2 (DE-588)1071861417 |
| title | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines |
| title_auth | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines |
| title_exact_search | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines |
| title_full | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines ed. by Syed F. Ali |
| title_fullStr | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines ed. by Syed F. Ali |
| title_full_unstemmed | Neurochemistry of drugs of abuse cocaine, ibogaine, and substituted amphetamines ed. by Syed F. Ali |
| title_short | Neurochemistry of drugs of abuse |
| title_sort | neurochemistry of drugs of abuse cocaine ibogaine and substituted amphetamines |
| title_sub | cocaine, ibogaine, and substituted amphetamines |
| topic | Amphétamines - Effets physiologiques - Congrès Cocaïne - Effets physiologiques - Congrès Drogues - Effets physiologiques - Congrès Drugs gtt Drugsgebruik gtt Ibogaine - Effets physiologiques - Congrès Neurochemie gtt Neurochimie - Congrès Neurotoxicologie - Congrès Toxicomanie - Aspect physiologique - Congrès Toxicomanie - Chimiothérapie - Congrès Amphetamines Physiological effect Congresses Amphetamines pharmacology Congresses Brain drug effects Congresses Cocaine Physiological effect Congresses Cocaine pharmacology Congresses Drug abuse Chemotherapy Congresses Drug abuse Physiological aspects Congresses Drugs of abuse Physiological effect Congresses Ibogaine Physiological effect Congresses Ibogaine pharmacology Congresses Neurochemistry Congresses Neurotoxicology Congresses Substance-Related Disorders physiopathology Congresses Neuropharmakologie (DE-588)4041896-0 gnd Neurotoxizität (DE-588)4123836-9 gnd Rauschgift (DE-588)4048610-2 gnd |
| topic_facet | Amphétamines - Effets physiologiques - Congrès Cocaïne - Effets physiologiques - Congrès Drogues - Effets physiologiques - Congrès Drugs Drugsgebruik Ibogaine - Effets physiologiques - Congrès Neurochemie Neurochimie - Congrès Neurotoxicologie - Congrès Toxicomanie - Aspect physiologique - Congrès Toxicomanie - Chimiothérapie - Congrès Amphetamines Physiological effect Congresses Amphetamines pharmacology Congresses Brain drug effects Congresses Cocaine Physiological effect Congresses Cocaine pharmacology Congresses Drug abuse Chemotherapy Congresses Drug abuse Physiological aspects Congresses Drugs of abuse Physiological effect Congresses Ibogaine Physiological effect Congresses Ibogaine pharmacology Congresses Neurochemistry Congresses Neurotoxicology Congresses Substance-Related Disorders physiopathology Congresses Neuropharmakologie Neurotoxizität Rauschgift Konferenzschrift 1997 Hamilton Bermudainseln |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008201537&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002532608 |
| work_keys_str_mv | AT alisyedf neurochemistryofdrugsofabusecocaineibogaineandsubstitutedamphetamines |